top of page

New Hope for ALS

  • Writer: anwilner
    anwilner
  • Aug 14, 2021
  • 1 min read

Updated: Aug 15, 2021

Please join me in this interview with Sabrina Paganoni, MD, Ph.D., who presented clinical trial results at the American Academy of Neurology 2021 Virtual Annual Meeting that promise new hope for patients with amyotrophic lateral sclerosis (ALS). A new drug, AMX0035, demonstrated functional improvement and survival benefit, according to Dr. Paganoni. Any hope for patients with this devastating disease is welcome!


Here's the 10-minute interview:


For more fascinating interviews, please check out "The Art of Medicine with Dr. Andrew Wilner" on YouTube: www.youtube.com/c/andrewwilnermdauthor

and your favorite podcast player.


Feedback is always appreciated!


Thanks for watching!






 
 
 

Commenti


        Ask a question!                                      For  media inquiries,

                                    please contact the author:

Thanks! Message sent.

Disclaimer: The author's website and books do not intend to provide professional business, medical, or legal advice and should not replace the counsel of an accountant, physician, or attorney, repsectively. Although the information has been carefully researched, the author assumes no liability for loss or damages resulting from its use.

 

Books and other products may have affiliate links. "As an Amazon Associate, I earn from qualifying purchases." (It's not much.) The price to you is the same.

Copywrite: Andrew Wilner, MD 2019.

bottom of page